Legend Biotech Corporation (LEGN) short interest & options flow
NASDAQLegend Biotech reports today with a stock that has surged 30% in a month yet still carries short interest above 8% of the free float, an unusual combination that makes the lending market the central story heading into the number. The borrow tension noted in October has eased slightly but has not resolved. Availability now sits at 43%, meaning roughly one share is available for…
LEGN short interest surges 22% in one week to 11% of float, highest level since June, as availability plummets 56% to 24%.
- Market cap
- $4.71B
- Next earnings
- 12 Nov 2026
Key data as of 10 Nov 2026

LEGN news and analysis
RSSNo long-form analysis yet for LEGN. Pulse alerts and the live data picture are available on ORTEX.
Open LEGN on ORTEX →Want the live picture for LEGN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LEGN — free to start on ORTEX.
Sign up for free →Open LEGN on ORTEX